Get the Stockscreener App
82.93
3.20%
-2.7386
After Hours:
82.97
0.04
+0.05%
Vaneck Pharmaceutical Etf stock is traded at $82.93, with a volume of 810.01K.
It is down -3.20% in the last 24 hours and down -5.72% over the past month.
See More
Previous Close:
$85.67
Open:
$84.62
24h Volume:
810.01K
Relative Volume:
1.66
Market Cap:
$907.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.40%
1M Performance:
-5.72%
6M Performance:
-6.74%
1Y Performance:
-10.90%
1-Day Range:
$82.66
$85.11
1-Week Range:
$82.66
$89.73
52-Week Range:
$77.67
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
Vaneck Pharmaceutical Etf
Sector
Industry
Phone
-
Address
-
Compare PPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
82.93 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
310.89 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
632.08 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
634.90 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
241.55 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
565.01 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - NewsBreak: Local News & Alerts
J&J leads big pharma higher after earnings despite Trump’s latest tariff threat - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
ETFs To Gain On JNJ's Solid Q1 Earnings & Upbeat Outlook - Barchart.com
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - Seeking Alpha
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center (PPH) - Seeking Alpha
Janney Montgomery Scott LLC Cuts Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Innovative Industrial Properties (NYSE:IIPR) Rating Lowered to Peer Perform at Wolfe Research - Defense World
Janney Montgomery Scott LLC Takes $448,000 Position in PUTNAM MAST INT (NYSE:PIM) - Defense World
Morgan Stanley Forecasts Strong Price Appreciation for ICL Group (NYSE:ICL) Stock - Defense World
Stifel Nicolaus Begins Coverage on Jabil (NYSE:JBL) - Defense World
Eaton Vance Enhanced Equity Income Fund II (NYSEARCA:EOS) Shares Sold by Cambridge Investment Research Advisors Inc. - Defense World
Petroleo Brasileiro S.A.- Petrobras (NYSE:PBR) Shares Sold by Janney Montgomery Scott LLC - Defense World
Microsoft Corporation (NASDAQ:MSFT) Shares Acquired by Fermata Advisors LLC - Defense World
PPH's Dividend Surge: A Healthcare Income Play in Volatile Markets - AInvest
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Benzinga
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Global pharma stocks down as Trump renews tariff threat - MSN
Short bets on S&P 500 Healthcare sector ease in May; MRNA stays most shorted stock - Seeking Alpha
Millennium Management LLC Lowers Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says pharma tariffs are coming in the “not-too-distant-future” - MSN
Ameriprise Financial Inc. Sells 3,806 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
Innovator Growth-100 Power Buffer ETF – September (NYSEARCA:NSEP) Holdings Lifted by Jane Street Group LLC - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Trims Stake in Vanguard S&P 500 Value ETF (NYSEARCA:VOOV) - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Stake Raised by Bank of America Corp DE - Defense World
Bank of America Corp DE Purchases 1,732 Shares of VanEck Retail ETF (NASDAQ:RTH) - Defense World
Gilead and Vertex Pharma named among biotech’s tariff safe havens - MSN
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - Inkl
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Comerica Bank - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Jane Street Group LLC - Defense World
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - TradingView
Do Wall Street Analysts Like Cencora Stock? - inkl
PPH, Big Pharma Stocks Volatile on Trump Drug Pricing - ETF.com
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
Biopharma Stocks Rise as Trump Orders Drug Price Cuts - Genetic Engineering and Biotechnology News
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):